AntidiabeticsINTRAVENOUS, SUBCUTANEOUSStandard
FIASP
INSULIN ASPART
Standard Dose
1000 UNITS/10ML (100 UNITS/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview FIASP is listed in Drugs@FDA under application 208751 (BLA).
Review priority: STANDARD Marketing status: Prescription Active ingredient INSULIN ASPART Form and strength SOLUTION;INTRAVENOUS, SUBCUTANEOUS - 1000 UNITS/10ML (100 UNITS/ML) Sponsor NOVO Submission history Latest submission status date: 2023-06-21 00:00:00.
Structured Monograph
Clinical summary
Approval overview FIASP is listed in Drugs@FDA under application 208751 (BLA). Review priority: STANDARD Marketing status: Prescription Active ingredient INSULIN ASPART Form and strength SOLUTION;INTRAVENOUS, SUBCUTANEOUS - 1000 UNITS/10ML (100 UNITS/ML) Sponsor NOVO Submission history Latest submission status date: 2023-06-21 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.